Two important downstream mediators of MEK/ERK signaling in NPM-ALK(+) ALCL are the serine/threonine kinase, mammalian target of rapamycin (mTOR), and the JunB transcription factor. Here, MARK2 is linked to anaplastic large cell lymphoma.